Special Issue "Multidrug-Resistant Pathogens"
Deadline for manuscript submissions: 31 August 2019
Dr. Despoina Koulenti
2nd Critical Care Department, Attikon University Hospital, Athens, Greece &BTCCRC, UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland Brisbane, Australia
Website | E-Mail
Interests: critical care; infectious diseases; sepsis; healthcare-associated infections; severe respiratory infections; multidrug-resistant microorganisms; antibiotic optimization; high fidelity medical simulation
Prof. Dr. Sotirios Tsiodras
Specialist of Internal Medicine & Infectious Diseases, 4th Department of Internal Medicine, University of Athens Medical School, 1 Rimini street, GR-12462 Haidari, Athens, Greece
Website | E-Mail
Interests: infectious diseases; sepsis; healthcare-associated infections; multidrug-resistant microorganisms; epidemiology; public health; virology
Background: Multidrug-resistant (MDR) pathogens represent a significant and ever-increasing threat to healthcare globally, as infections by MDR pathogens are related to increased morbidity, mortality, and healthcare costs. It has been reported that, by the year 2050, 10 million people will die annually as a consequence of MDR infections, unless a global and effective response is achieved to tackle the problem.
Goal: Further research is urgently needed to inform the best approaches for preventing and controlling the spread of MDR pathogens. Also, research on the development and validation of rapid diagnostic techniques that will enable the fast identification of resistance patterns and the development of novel antimicrobials is of paramount importance to improve the outcomes of MDR infections.
Scope: The scope of this Special Issue is to present the results of clinical and pre-clinical (experimental) research on multidrug-resistant (MDR) pathogens, as well as to present reviews that will advance the current knowledge on the topic and will act as a platform for further research.
Details for Authors: Original clinical (in humans, especially in the hospital setting) and experimental research articles on MDR pathogens. Reviews on the current measures for controlling the spread of MDR pathogens, as well as advances in the diagnosis and treatment of infections due to MDR pathogens.
Dr. Despoina Koulenti
Prof. Sotirios Tsiodras
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.